Legacy AI grade · Sources dated 2026-07-25. Not expert reviewed. Coverage is limited to the listed sources. About the new summary workflow
Iodine for Hypothyroidism
Across 6 PubMed studies, the evidence for Iodine in Hypothyroidism grades Tier C — weak evidence. Effective, but with safety or population caveats.
Why this grade7-layer evidence engine
Iodine is essential for thyroid hormone synthesis, but supplementing iodine in established hypothyroidism is not standard treatment. The Cochrane anchor (PMID 28260263) addresses pregnancy/preconception iodine supplementation, not hypothyroidism therapy.
Mayo Clinic L5b warns excess iodine can worsen hypothyroidism. Meta-analyses address deficiency/pregnancy populations, not clinical hypothyroidism management.
Tier C/PWW with scope warning is appropriate. Correct deficiency under medical supervision, but do not self-treat hypothyroidism with iodine supplements.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.448
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative),由 raw_score 決定
- tier_strict_requirement_check — Tier 條件達標,未降階
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status